Pathologic findings in postcardiotomy patients managed with a temporary left ventricular assist pump

Area of Science:

• Cardiovascular Surgery
• Mechanical Circulatory Support
• Critical Care Medicine

Background:

• Post-cardiotomy cardiogenic shock is a severe complication.
• Conventional treatments like pressors and intra-aortic balloons are often insufficient.
• Left ventricular assist devices (LVADs) offer a potential therapeutic option.

Purpose of the Study:

• To evaluate the efficacy and safety of temporary pneumatic left ventricular assist pump support.
• To assess hemodynamic improvement and long-term outcomes in patients with cardiogenic shock post-cardiotomy.
• To investigate the reversibility of myocardial dysfunction in these patients.

Main Methods:

• Twenty-one postcardiotomy patients in cardiogenic shock, unresponsive to other treatments, received temporary LVAD support.
• Patients were managed under a strict National Institutes of Health protocol.
• Myocardial biopsies and autopsy findings were analyzed to assess myocardial status.

Main Results:

• Nine patients demonstrated hemodynamic improvement after 91-190 hours of LVAD support.
• Three patients achieved long-term survival (33-39 months).
• Eight patients died due to hemorrhagic diathesis, often linked to prolonged cardiopulmonary bypass times.

Conclusions:

• Temporary LVAD support can be effective in postcardiotomy cardiogenic shock.
• Reversible myocardial dysfunction, potentially due to edema or ischemic injury, contributes to recovery.
• Hemorrhagic complications remain a significant risk, particularly with extended bypass durations.